CL2009001632A1 - Procedimiento de sintesis de agomelatina a partir de 3-metoxiacenaftoquinona; y uno de los compuestos intermediarios considerados en el procedimiento descrito. - Google Patents

Procedimiento de sintesis de agomelatina a partir de 3-metoxiacenaftoquinona; y uno de los compuestos intermediarios considerados en el procedimiento descrito.

Info

Publication number
CL2009001632A1
CL2009001632A1 CL2009001632A CL2009001632A CL2009001632A1 CL 2009001632 A1 CL2009001632 A1 CL 2009001632A1 CL 2009001632 A CL2009001632 A CL 2009001632A CL 2009001632 A CL2009001632 A CL 2009001632A CL 2009001632 A1 CL2009001632 A1 CL 2009001632A1
Authority
CL
Chile
Prior art keywords
formula
compound
described procedure
methoxyacenaphthoquinone
agomelatine
Prior art date
Application number
CL2009001632A
Other languages
English (en)
Inventor
Hardouin Christophe
Lecouve Jean-Pierre
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of CL2009001632A1 publication Critical patent/CL2009001632A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings

Abstract

COMPUESTO DE FORMULA I DONDE SE HACE REACCIONAR EN PRESENCIA DE UNA BASE FUERTE LA 3-METOXIACENALTOQUINONA DE FÓRMULA (11) : PARA DAR LUGAR AL COMPUESTO DE FÓRMULA (111) : QUE SE PONE EN CONDICIONES DE AMINACIÓN PARA DAR LUGAR AL COMPUESTO DE FÓRMULA (IV) QUE SE SOMETE A LA ACCIÓN DE UN SISTEMA REDUCTOR PARA DAR LUGAR AL COMPUESTO DE FÓRMULA (V): QUE SE SOMETE SUCESIVAMENTE A LA ACCIÓN DE ACETATO DE SODIO Y DE ANHIDRIDO ACÉTICO PARA DAR LUGAR AL COMPUESTO DE FÓRMULA (1) QUE SE AISLA EN LA FORMA DE UN SÓLIDO. UNO DE LOS COMPUESTOS INTERMEDIARIOS CONSIDERADOS EN EL PROCEDIMIENTO DESCRITO.
CL2009001632A 2008-08-05 2009-07-22 Procedimiento de sintesis de agomelatina a partir de 3-metoxiacenaftoquinona; y uno de los compuestos intermediarios considerados en el procedimiento descrito. CL2009001632A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0804464A FR2934855B1 (fr) 2008-08-05 2008-08-05 Nouveau procede de synthese de l'agomelatine

Publications (1)

Publication Number Publication Date
CL2009001632A1 true CL2009001632A1 (es) 2010-07-19

Family

ID=40409856

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009001632A CL2009001632A1 (es) 2008-08-05 2009-07-22 Procedimiento de sintesis de agomelatina a partir de 3-metoxiacenaftoquinona; y uno de los compuestos intermediarios considerados en el procedimiento descrito.

Country Status (46)

Country Link
US (1) US8143449B2 (es)
EP (1) EP2151429B1 (es)
JP (1) JP5021004B2 (es)
KR (1) KR101127357B1 (es)
CN (1) CN101643431B (es)
AP (1) AP2509A (es)
AR (1) AR074887A1 (es)
AT (1) ATE510816T1 (es)
AU (1) AU2009202905B2 (es)
BR (1) BRPI0903045A2 (es)
CA (1) CA2674764C (es)
CL (1) CL2009001632A1 (es)
CR (1) CR10934A (es)
CU (1) CU23858B1 (es)
CY (1) CY1111573T1 (es)
DK (1) DK2151429T3 (es)
EA (1) EA017684B1 (es)
EC (1) ECSP099549A (es)
ES (1) ES2367236T3 (es)
FR (1) FR2934855B1 (es)
GE (1) GEP20115344B (es)
GT (1) GT200900218A (es)
HK (1) HK1141004A1 (es)
HN (1) HN2009001435A (es)
HR (1) HRP20110568T1 (es)
IL (1) IL199875A (es)
JO (1) JO2821B1 (es)
MA (1) MA31830B1 (es)
ME (1) ME00927B (es)
MX (1) MX2009007971A (es)
MY (1) MY144746A (es)
NI (1) NI200900152A (es)
NZ (1) NZ578381A (es)
PE (1) PE20100259A1 (es)
PL (1) PL2151429T3 (es)
PT (1) PT2151429E (es)
RS (1) RS51740B (es)
SA (1) SA109300498B1 (es)
SG (1) SG158814A1 (es)
SI (1) SI2151429T1 (es)
SV (1) SV2009003344A (es)
TW (1) TWI376365B (es)
UA (1) UA106195C2 (es)
UY (1) UY31985A (es)
WO (1) WO2010015746A1 (es)
ZA (1) ZA200905051B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2011001405A1 (es) 2010-06-10 2012-03-30 Gador S A Conicet Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina.
CN102531956B (zh) * 2010-12-21 2014-07-09 浙江九洲药业股份有限公司 用于制备阿戈美拉汀的中间体及相关制备方法
US8561395B2 (en) 2011-03-03 2013-10-22 Tenneco Automotive Operating Company Inc. Poka-yoke mounting system for an exhaust treatment device
EP2562151A1 (en) * 2011-08-25 2013-02-27 Dr. Reddy's Laboratories Ltd. Processes for the preparation of agomelatine and its intermediates
ITMI20121444A1 (it) 2012-08-27 2014-02-28 Procos Spa Processo per la produzione di agomelatine
FR3014437B1 (fr) * 2013-12-05 2016-12-23 Servier Lab Nouveau procede de synthese de l'agomelatine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US6037495A (en) * 1994-09-06 2000-03-14 Shinonogi & Co., Ltd. Process for producing alkoxyiminoacetamide derivatives
FR2734816B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
MA31830B1 (fr) 2010-11-01
CU20090131A7 (es) 2011-05-27
IL199875A0 (en) 2010-05-17
AR074887A1 (es) 2011-02-23
EA200900943A1 (ru) 2010-04-30
SA109300498B1 (ar) 2013-07-23
EP2151429B1 (fr) 2011-05-25
JP5021004B2 (ja) 2012-09-05
FR2934855B1 (fr) 2010-08-13
WO2010015746A1 (fr) 2010-02-11
SV2009003344A (es) 2010-02-05
JO2821B1 (en) 2014-09-15
MY144746A (en) 2011-10-31
AP2509A (en) 2012-11-19
HRP20110568T1 (en) 2011-09-30
PE20100259A1 (es) 2010-04-10
NZ578381A (en) 2010-11-26
ES2367236T3 (es) 2011-10-31
HK1141004A1 (en) 2010-10-29
US8143449B2 (en) 2012-03-27
ME00927B (me) 2012-06-20
AU2009202905B2 (en) 2013-09-05
PT2151429E (pt) 2011-07-11
IL199875A (en) 2013-10-31
CR10934A (es) 2009-10-15
KR20100017060A (ko) 2010-02-16
PL2151429T3 (pl) 2011-11-30
CN101643431B (zh) 2013-05-15
FR2934855A1 (fr) 2010-02-12
CA2674764C (fr) 2012-04-17
JP2010043078A (ja) 2010-02-25
EP2151429A1 (fr) 2010-02-10
MX2009007971A (es) 2010-03-25
AP2009004929A0 (en) 2009-08-31
UY31985A (es) 2010-01-29
CA2674764A1 (fr) 2010-02-05
SG158814A1 (en) 2010-02-26
TWI376365B (en) 2012-11-11
RS51740B (en) 2011-10-31
CU23858B1 (es) 2013-02-26
CN101643431A (zh) 2010-02-10
AU2009202905A1 (en) 2010-02-25
TW201018658A (en) 2010-05-16
ZA200905051B (en) 2010-05-26
HN2009001435A (es) 2011-12-27
DK2151429T3 (da) 2011-09-19
SI2151429T1 (sl) 2011-09-30
CY1111573T1 (el) 2015-10-07
ECSP099549A (es) 2010-03-31
BRPI0903045A2 (pt) 2010-05-25
UA106195C2 (ru) 2014-08-11
US20100036163A1 (en) 2010-02-11
NI200900152A (es) 2010-03-25
EA017684B1 (ru) 2013-02-28
ATE510816T1 (de) 2011-06-15
GEP20115344B (en) 2011-12-12
KR101127357B1 (ko) 2012-04-12
GT200900218A (es) 2010-08-23

Similar Documents

Publication Publication Date Title
CL2009001632A1 (es) Procedimiento de sintesis de agomelatina a partir de 3-metoxiacenaftoquinona; y uno de los compuestos intermediarios considerados en el procedimiento descrito.
ES2498519T3 (es) Un procedimiento para la fabricación de SNAC (SALCAPROZATO SÓDICO)
CO6120163A1 (es) Nuevo procedimeinto de sintesis de la agomelatina
AR065137A1 (es) Procesos e intermediarios para la preparacion de un inhibidor de proteasa macrociclico del vhc y metodos de obtencion de los mencionados intermediarios.
MY162033A (en) New process for the synthesis of agomelatine
AR077701A1 (es) Compuestos antiproliferativos, conjugados de los mismos, procedimientos para estos, y usos de los mismos
AR070642A1 (es) Procedimiento de sintesis del (7- metoxi-1 naftil) acetonitrilo y aplicacion a la sintesis de la agomelatina
MY153613A (en) Method for synthesizing an omega-amino acid or ester from a monounsaturated fatty acid or ester
AR074863A1 (es) Proceso y compuestos intermedios para preparar un inhibidor de proteasa macrociclico del vhc
ECSP10010215A (es) Procedimiento para la preparación de ésteres alquílicos de ácidos grasos
UA100367C2 (uk) Спосіб одержання мемантину і його гідрохлориду
RS54201B1 (en) PROCEDURE FOR PREPARATION OF BIFENYL-2-ILCARBAMIC ACID
BR112012007554A2 (pt) método para a fabricação de ácidos amino hidróxi disfofônico
AR078916A1 (es) Procedimiento para la purificacion de paliperidona
UA107815C2 (uk) Спосіб одержання акрилової та метакрилової кислоти
AR049668A1 (es) Proceso quimico para preparar esteres de 4,4 - difluorometil - 3 - oxo - butanoico por reaccion entre una amida y un ester.
HN2010001700A (es) Procedimiento de preparacion de combretastatina
AR071259A1 (es) Procedimiento para preparar un acido gamma-amino sustituido y composiciones farmaceuticas que contienen dicho compuesto
ECSP088679A (es) Proceso para la preparacion de compuestos de dibenzotiazepina
UA102816C2 (ru) Способ синтеза кристаллической формы v агомелатина
MA31745B1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
AR066054A1 (es) Proceso para preparar galantamina
AR065724A1 (es) Macrolidos
PL419800A1 (pl) Kwas (4-tert-butylo-1-etenylocykloheks-1-ylo)octowy i sposób jego wytwarzania
PE20080148A1 (es) Nuevo proceso para sintesis y nueva forma cristalna de agomelatina y composiciones farmaceuticas que la contienen